Abstract
Homocysteine (Hcy) is a sulfur-containing amino acid derived from methionine metabolism. Elevated plasma Hcy levels (> 15 µM) result in a condition called hyperhomocysteinemia (HHcy), which is an independent risk factor in the development of various neurodegenerative disorders. Reactive oxygen species (ROS) produced by auto-oxidation of Hcy have been implicated in HHcy-associated neurological conditions. Hydrogen sulfide (H2S) is emerging as a potent neuroprotective and neuromodulator molecule. The present study was aimed to evaluate the ability of NaHS (a source of H2S) to attenuate Hcy-induced oxidative stress and altered antioxidant status in animals subjected to HHcy. Impaired cognitive functions assessed by Y-maze and elevated plus maze in Hcy-treated animals were reversed on NaHS administration. Increased levels of ROS, lipid peroxidation, protein carbonyls, and 4-hydroxynonenal (4-HNE)-modified proteins were observed in the cortex and hippocampus of Hcy-treated animals suggesting accentuated oxidative stress. This increase in Hcy-induced oxidative stress was reversed following NaHS supplementation. GSH/GSSG ratio, activity of antioxidant enzymes viz; superoxide dismutase, glutathione peroxidase, glutathione reductase, and glutathione-S-transferase were decreased in Hcy-treated animals. NaHS supplementation, on the otherhand, restored redox ratio and activity of antioxidant enzymes in the brains of animals with HHcy. Further, NaHS administration normalized nuclear factor erythroid 2-related factor 2 expression and acetylcholinesterase (AChE) activity in the brain of Hcy-treated animals. Histopathological studies using cresyl violet indicated higher number of pyknotic neurons in the cortex and hippocampus of HHcy animals, which were reversed by NaHS administration. The results clearly demonstrate that NaHS treatment significantly ameliorates Hcy-induced cognitive impairment by attenuating oxidative stress, improving antioxidant status, and modulating AChE activity thereby suggesting potential of H2S as a therapeutic molecule.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agnati, L. F., Genedani, S., Rasio, G., Galantucci, M., Saltini, S., Filaferro, M., et al. (2005). Studies on homocysteine plasma levels in Alzheimer’s patients. Relevance for neurodegeneration. Journal of Neural Transmission, 112(1), 163–169. https://doi.org/10.1007/s00702-004-0154-7.
Benetti, L. R., Campos, D., Gurgueira, S. A., Vercesi, A. E., Guedes, C. E. V., Santos, K. L., et al. (2013). Hydrogen sulfide inhibits oxidative stress in lungs from allergic mice in vivo. European Journal of Pharmacology, 698(1–3), 463–469. https://doi.org/10.1016/j.ejphar.2012.11.025.
Blokland, A. (1995). Acetylcholine: A neurotransmitter for learning and memory? Brain Research Reviews, 21(3), 285–300.
Boldyrev, A., Bryushkova, E., Mashkina, A., & Vladychenskaya, E. (2013). Why is homocysteine toxic for the nervous and immune systems? Current Aging Science, 6(1), 29–36.
Butterfield, D. A., Castegna, A., Lauderback, C. M., & Drake, J. (2002). Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death. Neurobiology of Aging, 23(5), 655–664.
Capiotti, K. M., De Moraes, D. A., Menezes, F. P., Kist, L. W., Bogo, M. R., & Da Silva, R. S. (2014). Hyperglycemia induces memory impairment linked to increased acetylcholinesterase activity in zebrafish (Danio rerio). Behavioural Brain Research, 274, 319–325. https://doi.org/10.1016/j.bbr.2014.08.033.
Carlberg, I., & Mannervik, B. (1985). Glutathione reductase. Methods in Enzymology, 113, 484–490.
Castro, R., Rivera, I., Blom, H. J., Jakobs, C., & Tavares de Almeida, I. (2006). Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview. Journal of Inherited Metabolic Disease, 29(1), 3–20. https://doi.org/10.1007/s10545-006-0106-5.
da Cunha, A. A., Ferreira, A. G. K., Loureiro, S. O., da Cunha, M. J., Schmitz, F., Netto, C. A., & Wyse, A. T. (2012a). Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats. Neurochemical Research, 37(8), 1660–1669. https://doi.org/10.1007/s11064-012-0769-2.
da Cunha, M. J., da Cunha, A. A., Ferreira, A. G. K., Machado, F. R., Schmitz, F., Lima, D. D., et al. (2012b). Physical exercise reverses glutamate uptake and oxidative stress effects of chronic homocysteine administration in the rat. International Journal of Developmental Neuroscience, 30(2), 69–74. https://doi.org/10.1016/j.ijdevneu.2012.01.001.
Dayal, S., Arning, E., Bottiglieri, T., Boger, R. H., Sigmund, C. D., Faraci, F. M., & Lentz, S. R. (2004). Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke, 35(8), ,1957–1962.
Dhanda, S., & Sandhir, R. (2015). Role of dopaminergic and serotonergic neurotransmitters in behavioral alterations observed in rodent model of hepatic encephalopathy. Behavioural Brain Research, 286, 222–235. https://doi.org/10.1016/j.bbr.2015.01.042.
Elanchezhian, R., Palsamy, P., Madson, C. J., Lynch, D. W., & Shinohara, T. (2012). Age-related cataracts: Homocysteine coupled endoplasmic reticulum stress and suppression of Nrf2-dependent antioxidant protection. Chemico-Biological Interactions, 200(1), 1–10. https://doi.org/10.1016/j.cbi.2012.08.017.
Fernandes, V. S., Xin, W., & Petkov, G. V. (2015). Novel mechanism of hydrogen sulfide-induced guinea pig urinary bladder smooth muscle contraction: role of BK channels and cholinergic neurotransmission. American Journal of Physiology-Cell Physiology, 309(2), C107–C116. https://doi.org/10.1152/ajpcell.00021.2015.
Flohé, L., & Günzler, W. A. (1984). Assays of glutathione peroxidase. Methods in Enzymology, 105, 114–121.
Guo, Y., Yu, S., Zhang, C., & Kong, A.-N. T. (2015). Epigenetic regulation of Keap1-Nrf2 signaling. Free Radical Biology and Medicine, 88(Pt B), 337–349. https://doi.org/10.1016/j.freeradbiomed.2015.06.013.
Habig, W. H., Pabst, M. J., & Jakoby, W. B. (1974). Glutathione S-Transferases the first enzymatic step in mercapturic acid formation*. The Journal of Biological Chemistry, 249(22), 7130–7139.
Hayden, M. R., & Tyagi, S. C. (2004). Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutrition Journal, 3, 4. https://doi.org/10.1186/1475-2891-3-41475-2891-3-4.
Hissin, P. J., & Hilf, R. (1976). A fluorometric method for determination of oxidized and reduced glutathione in tissues. Analytical Biochemistry, 74(1), 214–226.
Hrnčić, D., -Marković, R., Stojković, A., Velimirović, T., Puškaš, M., Obrenović, N., R., et al (2014). Hyperhomocysteinemia induced by methionine dietary nutritional overload modulates acetylcholinesterase activity in the rat brain. Molecular and Cellular Biochemistry, 396(1–2), 99–105. https://doi.org/10.1007/s11010-014-2146-8.
Hu, L. F., Lu, M., Wu, Z. Y., Wong, P. T., & Bian, J. S. (2009). Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function. Molecular Pharmacology, 75(1), 27–34. https://doi.org/10.1124/mol.108.047985.
Hu, L. F., Wong, P. T., Moore, P. K., & Bian, J. S. (2007). Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. Journal of Neurochemistry, 100(4), 1121–1128. https://doi.org/10.1111/j.1471-4159.2006.04283.x.
Itoh, J., Nabeshima, T., & Kameyama, T. (1990). Utility of an elevated plus-maze for the evaluation of memory in mice: Effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology (Berl), 101(1), 27–33. https://doi.org/10.1007/BF02253713.
Kamat, P. K., Kalani, A., Givvimani, S., Sathnur, P. B., Tyagi, S. C., & Tyagi, N. (2013). Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice. Neuroscience, 252, 302–319. https://doi.org/10.1016/j.neuroscience.2013.07.051
Kamat, P. K., Kyles, P., Kalani, A., & Tyagi, N. (2016). Hydrogen sulfide ameliorates homocysteine-induced alzheimer’s disease-like pathology, blood–brain barrier disruption, and synaptic disorder. Molecular Neurobiology, 53(4), 2451–2467. https://doi.org/10.1007/s12035-015-9212-4.
Kansanen, E., Kuosmanen, S. M., Leinonen, H., & Levonen, A.-L. (2013). The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biology, 1(1), 45–49. https://doi.org/10.1016/j.redox.2012.10.001.
Kimura, H. (2002). Hydrogen sulfide as a neuromodulator. Molecular Neurobiology, 26(1), 13–19. https://doi.org/10.1385/MN:26:1:013.
Kimura, H. (2005). Hydrogen sulfide as a biological mediator. Antioxidants & Redox Signaling, 7(5–6), 778–780. https://doi.org/10.1089/ars.2005.7.778.
Kimura, H., Shibuya, N., & Kimura, Y. (2012). Hydrogen sulfide is a signaling molecule and a cytoprotectant. Antioxidants & Redox Signaling, 17(1), 45–57. https://doi.org/10.1089/ars.2011.4345.
Kimura, Y., Goto, Y.-I., & Kimura, H. (2010). Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxidants & Redox Signaling, 12(1), 1–13. https://doi.org/10.1089/ars.2008.2282.
Kimura, Y., & Kimura, H. (2004). Hydrogen sulfide protects neurons from oxidative stress. The FASEB Journal, 18(10), 1165–1167. https://doi.org/10.1096/fj.04-1815fje04-1815fje.
Kono, Y. (1978). Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Archives of Biochemistry and Biophysics, 186(1), 189–195.
Kroker, K. S., Rast, G., Giovannini, R., Marti, A., Dorner-Ciossek, C., & Rosenbrock, H. (2012). Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP. Neuropharmacology, 62(5–6), 1964–1974. https://doi.org/10.1016/j.neuropharm.2011.12.021.
Kumar, M., Goudihalli, S., Mukherjee, K., Dhandapani, S., & Sandhir, R. (2018a). Methylenetetrahydrofolate reductase C677T variant and hyperhomocysteinemia in subarachnoid hemorrhage patients from India. Metabolic Brain Disease. https://doi.org/10.1007/s11011-018-0268-5.
Kumar, M., Modi, M., & Sandhir, R. (2017). Hydrogen sulfide attenuates homocysteine-induced cognitive deficits and neurochemical alterations by improving endogenous hydrogen sulfide levels. BioFactors, 43(3), 434–450. https://doi.org/10.1002/biof.1354.
Kumar, M., Ray, R. S., & Sandhir, R. (2018b). Hydrogen sulfide attenuates homocysteine-induced neurotoxicity by preventing mitochondrial dysfunctions and oxidative damage: In vitro and in vivo studies. Neurochemistry International, 120, 87–98. https://doi.org/10.1016/j.neuint.2018.07.010.
Kumar, M., & Sandhir, R. (2018). Hydrogen sulfide in physiological and pathological mechanisms in brain. CNS & Neurological Disorders-Drug Targets. doi:https://doi.org/10.2174/1871527317666180605072018.
Lehotský, J., Tothová, B., Kovalská, M., Dobrota, D., Beňová, A., Kalenská, D., & Kaplán, P. (2016). Role of homocysteine in the ischemic stroke and development of ischemic tolerance. Frontiers in Neuroscience, 10, 538. https://doi.org/10.3389/fnins.2016.00538.
Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A. G., et al. (1990). Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology, 186, 464–478.
Li, M., Zhang, P., Wei, H. J., Li, M. H., Zou, W., Li, X., et al. (2017). Hydrogen sulfide ameliorates homocysteine-induced cognitive dysfunction by inhibition of reactive aldehydes involving upregulation of ALDH2. International Journal of Neuropsychopharmacology, 20(4), 305–315. https://doi.org/10.1093/ijnp/pyw103.
Li, M.-H., Tang, J.-P., Zhang, P., Li, X., Wang, C.-Y., Wei, H.-J., et al. (2014). Disturbance of endogenous hydrogen sulfide generation and endoplasmic reticulum stress in hippocampus are involved in homocysteine-induced defect in learning and memory of rats. Behavioural Brain Research, 262, 35–41. https://doi.org/10.1016/j.bbr.2014.01.001.
Lipton, S. A., Kim, W. K., Choi, Y. B., Kumar, S., D’Emilia, D. M., Rayudu, P. V., et al. (1997). Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proceedings of the National Academy of Sciences of the United States of America, 94(11), 5923–5928.
Liu, Y., Deng, Y., Liu, H., Yin, C., Li, X., & Gong, Q. (2016). Hydrogen sulfide ameliorates learning memory impairment in APP/PS1 transgenic mice: A novel mechanism mediated by the activation of Nrf2. Pharmacology Biochemistry and Behavior, 150–151, 207–216. https://doi.org/10.1016/j.pbb.2016.11.002.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry, 193(1), 265–275.
Lu, M., Hu, L. F., Hu, G., & Bian, J. S. (2008). Hydrogen sulfide protects astrocytes against H(2)O(2)-induced neural injury via enhancing glutamate uptake. Free Radical Biology & Medicine, 45(12), 1705–1713. https://doi.org/10.1016/j.freeradbiomed.2008.09.014.
Lu, M., Zhao, F.-F., Tang, J.-J., Su, C.-J., Fan, Y., Ding, J.-H., et al. (2012). The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels. Antioxidants & Redox Signaling, 17(6), 849–859. https://doi.org/10.1089/ars.2011.4507.
Lubos, E., Loscalzo, J., & Handy, D. E. (2007). Homocysteine and glutathione peroxidase-1. Antioxidants & Redox Signaling, 9(11), 1923–1940. https://doi.org/10.1089/ars.2007.1771.
Lück, H. (1965). Catalase. In H.-U. Bergmeyer (Ed.), Methods of enzymatic analysis (second printing, revised) (Second Pri., pp. 885–894). Cambridge: Academic Press. https://doi.org/10.1016/B978-0-12-395630-9.50158-4.
Luna-Sánchez, M., Hidalgo-Gutiérrez, A., Hildebrandt, T. M., Chaves-Serrano, J., Barriocanal-Casado, E., Santos-Fandila, Á, et al. (2017). CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome. EMBO Molecular Medicine, 9(1), 78–95. https://doi.org/10.15252/emmm.201606345.
Ma, Q. (2013). Role of Nrf2 in oxidative stress and toxicity. Annual Review of Pharmacology and Toxicology, 53(1), 401–426. https://doi.org/10.1146/annurev-pharmtox-011112-140320.
Matté, C., Pereira, L. O., Santos, D., Mackedanz, T. M., Cunha, V., Netto, A. A., C. A., & Wyse, A. T. S. (2009). Acute homocysteine administration impairs memory consolidation on inhibitory avoidance task and decreases hippocampal brain-derived neurotrophic factor immunocontent: Prevention by folic acid treatment. Neuroscience, 163(4), 1039–1045. https://doi.org/10.1016/j.neuroscience.2009.07.023.
McCully, K. S. (2015). Homocysteine metabolism, atherosclerosis, and diseases of aging. Comprehensive Physiology, 6, 471–505. https://doi.org/10.1002/cphy.c150021.
Melo, J. B., Agostinho, P., & Oliveira, C. R. (2003). Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neuroscience Research, 45(1), 117–127. https://doi.org/10.1016/S0168-0102(02)00201-8.
Miller, J. W. (1999). Homocysteine and Alzheimer’s disease. Nutrition Reviews, 57(4), 126–129.
Moreira, D. D. S., Figueiró, P. W., Siebert, C., Prezzi, C. A., Rohden, F., Guma, F. C. R., et al. (2017). Chronic mild hyperhomocysteinemia alters inflammatory and oxidative/nitrative status and causes protein/DNA damage, as well as ultrastructural changes in cerebral cortex : Is acetylsalicylic acid neuroprotective ? Neurotoxicity Research, 33(3), 580–592.
Ogita, K., Okuda, H., Yamamoto, Y., Nishiyama, N., & Yoneda, Y. (2003). In vivo neuroprotective role of NMDA receptors against kainate-induced excitotoxicity in murine hippocampal pyramidal neurons. Journal of Neurochemistry, 85(5), 1336–1346.
Ohkawa, S., Fukatsu, K., Miki, S., Hashimoto, T., Sakamoto, J., Doi, T., et al. (1997). 5-Aminocoumarans: Dual inhibitors of lipid peroxidation and dopamine release with protective effects against central nervous system trauma and ischemia. Journal of Medicinal Chemistry, 40(4), 559–573. https://doi.org/10.1021/jm960411j.
Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research, 29(9), e45.
Prawan, A., Kundu, J. K., & Surh, Y.-J. (2005). Molecular basis of heme oxygenase-1 induction: Implications for chemoprevention and chemoprotection. Antioxidants & Redox Signaling, 7(11–12), 1688–1703. https://doi.org/10.1089/ars.2005.7.1688.
Rivero-Gutiérrez, B., Anzola, A., Martínez-Augustin, O., & De Medina, F. S. (2014). Stain-free detection as loading control alternative to Ponceau and housekeeping protein immunodetection in Western blotting. Analytical Biochemistry, 467, 1–3. https://doi.org/10.1016/j.ab.2014.08.027.
Rossoni, G., Manfredi, B., Razzetti, R., Civelli, M., & Berti, F. (2007). Positive interaction of the novel β2-agonist carmoterol and tiotropium bromide in the control of airway changes induced by different challenges in guinea-pigs. Pulmonary Pharmacology & Therapeutics, 20(3), 250–257. https://doi.org/10.1016/j.pupt.2006.01.004.
Rossoni, G., Sparatore, A., Tazzari, V., Manfredi, B., Del Soldato, P., & Berti, F. (2008). The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart. British Journal of Pharmacology, 153(1), 100–109. https://doi.org/10.1038/sj.bjp.0707540.
Sachdev, P. S. (2005). Homocysteine and brain atrophy. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(7), 1152–1161. https://doi.org/10.1016/j.pnpbp.2005.06.026.
Scherer, E. B., da Cunha, A. A., Kolling, J., da Cunha, M. J., Schmitz, F., Sitta, A., et al. (2011). Development of an animal model for chronic mild hyperhomocysteinemia and its response to oxidative damage. International Journal of Developmental Neuroscience, 29(7), 693–699. https://doi.org/10.1016/j.ijdevneu.2011.06.004.
Stamler, J. S., Osborne, J. A., Jaraki, O., Rabbani, L. E., Mullins, M., Singel, D., & Loscalzo, J. (1993). Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. Journal of Clinical Investigation, 91(1), 308–318. https://doi.org/10.1172/JCI116187.
Stipanuk, M. H. (2004). Sulfur amino acid metabolism: Pathways for production and removal of homocysteine and cysteine. Annual Review of Nutrition, 24, 539–577. https://doi.org/10.1146/annurev.nutr.24.012003.132418.
Surh, Y.-J., Kundu, J., & Na, H.-K. (2008). Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Medica, 74(13), 1526–1539. https://doi.org/10.1055/s-0028-1088302.
Surh, Y.-J., & Na, H.-K. (2008). NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes & Nutrition, 2(4), 313–317. https://doi.org/10.1007/s12263-007-0063-0.
Tang, X. Q., Yang, C. T., Chen, J., Yin, W. L., Tian, S. W., Hu, B., et al. (2008). Effect of hydrogen sulphide on beta-amyloid-induced damage in PC12 cells. Clinical and Experimental Pharmacology and Physiology, 35(2), 180–186. https://doi.org/10.1111/j.1440-1681.2007.04799.x.
Towbin, H., Staehelint, T., & Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proceedings of the National Academy of Sciences, 76(9), 4350–4354.
Tyagi, N., Moshal, K. S., Sen, U., Vacek, T. P., Kumar, M., Hughes, W. M., et al. (2009). H2S protects against methionine? Induced oxidative stress in brain endothelial cells. Antioxidants & Redox Signaling, 11(1), 25–33. https://doi.org/10.1089/ars.2008.2073.
Wang, H., & Joseph, J. A. (1999). Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radical Biology & Medicine, 27(5–6), 612–616.
Wang, X., & Yang, H. (2016). Upregulation of CBS/H2S system contributes to asymmetric dimethylarginine-triggered protection against the neurotoxicity of glutamate to PC12 cells by inhibiting NOS/NO pathway. Experimental Cell Research, 346(1), 111–118. https://doi.org/10.1016/j.yexcr.2016.06.010.
Wei, H., Xu, J., Li, M., Tang, J., Zou, W., Zhang, P., et al. (2014). Hydrogen sulfide inhibits homocysteine-induced endoplasmic reticulum stress and neuronal apoptosis in rat hippocampus via upregulation of the BDNF-TrkB pathway. Acta Pharmacologica Sinica, 35(6), 707–715. https://doi.org/10.1038/aps.2013.197.
Whiteman, M., Cheung, N. S., Zhu, Y. Z., Chu, S. H., Siau, J. L., Wong, B. S., et al. (2005). Hydrogen sulphide: A novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochemical and Biophysical Research Communications, 326(4), 794–798. https://doi.org/10.1016/j.bbrc.2004.11.110.
Whittaker, M. (1986). Cholinesterase. Basel: Karger. https://doi.org/10.1159/isbn.978-3-318-04003-6.
Wu, D., Zheng, N., Qi, K., Cheng, H., Sun, Z., Gao, B., et al. (2015). Exogenous hydrogen sulfide mitigates the fatty liver in obese mice through improving lipid metabolism and antioxidant potential. Medical Gas Research, 5(1), 1. https://doi.org/10.1186/s13618-014-0022-y.
Xie, L., Gu, Y., Wen, M., Zhao, S., Wang, W., Ma, Y., et al. (2016). Hydrogen sulfide induces Keap1 S-sulfhydration and suppresses diabetes-accelerated atherosclerosis via Nrf2 activation. Diabetes, 65(10), 3171–3184. https://doi.org/10.2337/db16-0020.
Xuan, A., Long, D., Li, J., Ji, W., Zhang, M., Hong, L., & Liu, J. (2012). Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in β-amyloid rat model of Alzheimer’s disease. Journal of Neuroinflammation, 9, 202. https://doi.org/10.1186/1742-2094-9-202.
Yang, S., Yang, X., & Cao, G. (2015). Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells. Molecular Medicine Reports, 12(1), 1145–1150. https://doi.org/10.3892/mmr.2015.3490.
Zhang, C.-E., Wei, W., Liu, Y.-H., Peng, J.-H., Tian, Q., Liu, G.-P., et al. (2009). Hyperhomocysteinemia Increases β-amyloid by enhancing expression of γ-secretase and phosphorylation of amyloid precursor protein in rat brain. The American Journal of Pathology, 174(4), 1481–1491. https://doi.org/10.2353/ajpath.2009.081036.
Zhang, Y., Tang, Z.-H., Ren, Z., Qu, S.-L., Liu, M.-H., Liu, L.-S., & Jiang, Z.-S. (2013). Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases. Molecular and Cellular Biology, 33(6), 1104–1113. https://doi.org/10.1128/MCB.01215-12.
Zhao, H., Qu, J., Li, Q., Cui, M., Wang, J., Zhang, K., et al. (2017). Taurine supplementation reduces neuroinflammation and protects against white matter injury after intracerebral hemorrhage in rats. Amino Acids, 50(3–4), 439–451.
Acknowledgements
The financial assistance provided by the Department of Bio-Technology (DBT), Govt. of India, New Delhi (Grant No. BT/361/NE/TBP/2012) is acknowledged. The fellowship to MK from the University Grants Commission (UGC), New Delhi [F.17-7(J)/2004(SA-1)] is also acknowledged. The authors also acknowledge financial assistance provided by Department of Science and Technology (DST) New Delhi, under the Promotion of University Research and Scientific Excellence (PURSE) and by UGC under the Special Assistance Program (UGC-SAP DRS phase-II).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author states no conflict of interest.
Rights and permissions
About this article
Cite this article
Kumar, M., Sandhir, R. Neuroprotective Effect of Hydrogen Sulfide in Hyperhomocysteinemia Is Mediated Through Antioxidant Action Involving Nrf2. Neuromol Med 20, 475–490 (2018). https://doi.org/10.1007/s12017-018-8505-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-018-8505-y